2012 annual financial data
Alnylam Pharmaceuticals 2012 Financial results
Direct answer
Revenue was 66.73M USD.
Operating income was -129.46M USD and net income was -106.01M USD.
Operating cash flow was -115.61M USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 66.73M USD
- Operating income
- -129.46M USD
- Net income
- -106.01M USD
- Operating cash flow
- -115.61M USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Alnylam Pharmaceuticals financial years